Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Feline Rotavirus A as a Source of Spillover Infections to Humans: An In-Depth Analysis of Molecular Epidemiological Evidence. | Viruses | 2026 | 41754550 | PubTator, text mining | PubMed |
| Targeting SARS-CoV-2 Main Protease: A Bacteria-Based Colorimetric Assay for Screening Natural Antiviral Inhibitors. | Viruses | 2026 | 41754521 | PubTator, text mining | PubMed |
| Plant-Derived Secondary Metabolites Modulating Inflammation-Driven Pathways in Hepatocellular Carcinoma: Preclinical Insights. | Curr Issues Mol Biol | 2026 | 41751435 | PubTator, text mining | PubMed |
| Research Progress and Applications of the Rotavirus Reverse Genetics System. | Animals (Basel) | 2026 | 41751070 | PubTator, text mining | PubMed |
| Neuropsychiatric Phenotype and Treatment Challenges in 47,XYY Syndrome: A Narrative Review with a Case Series of Adolescents. | Brain Sci | 2026 | 41750232 | PubTator, text mining | PubMed |
| Rewriting the viral script: post-translational modifications orchestrating SARS-CoV-2 pathogenesis and immune evasion. | Front Microbiol | 2026 | 41743132 | PubTator, text mining | PubMed |
| Leveraging knowledge graphs and large language models for integrating molecular variants and clinical insights in COVID-19 research. | Biosaf Health | 2026 | 41743026 | PubTator, text mining | PubMed |
| Unbiased cleavage site prediction uncovers viral antagonism of host innate immunity by SARS-CoV-2 3C-like protease. | JCI Insight | 2026 | 41729072 | PubTator, text mining | PubMed |
| RNA-seq variants reveal distinct patterns in the aging epitranscriptome: an in-depth analysis of age-matched Alzheimer's Disease patients and a cognitively normal cohort. | bioRxiv | 2026 | 41727166 | PubTator, text mining | PubMed |
| Unlocking the secrets of SARS-CoV-2 nsp3 by combining experiments with AlphaFold2 domain prediction. | Life Sci Alliance | 2026 | 41720606 | PubTator, text mining | PubMed |
| Impact of cellular proteases on the function of antiviral antibodies. | J Virol | 2026 | 41711444 | PubTator, text mining | PubMed |
| Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor. | J Med Chem | 2026 | 41663073 | PubTator, text mining | PubMed |
| Mechanistic insights into the noncovalent inhibition of SARS-CoV-2 PLpro: a multiscale computational study. | J Comput Aided Mol Des | 2026 | 41639476 | PubTator, text mining | PubMed |
| Theaflavin Suppresses PEDV Replication via Inhibiting PI3K/Akt/mTOR Signaling and Directly Interacting with Viral Proteins. | J Agric Food Chem | 2026 | 41636359 | PubTator, text mining | PubMed |
| Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC. | J Immunother Cancer | 2026 | 41592891 | PubTator, text mining | PubMed |
| A novel bat-like human G3P[10] rotavirus strain from Thailand shares its VP7 lineage with equine Erv105 and human DS-1-like G3P[8] strains: a possible origin in bats. | Virology | 2026 | 41558444 | PubTator, text mining | PubMed |
| Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main protease. | Sci Adv | 2026 | 41544157 | PubTator, text mining | PubMed |
| Genomic and antigenic analysis of G1P[8] rotavirus strains in Ningxia, China. | Int J Infect Dis | 2026 | 41519377 | PubTator, text mining | PubMed |
| APOBEC3F restricts PRRSV replication through its CD2 domain and interaction with host antiviral proteins. | Vet Microbiol | 2026 | 41494272 | PubTator, text mining | PubMed |
| A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 - present). | Expert Opin Ther Pat | 2026 | 41348159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=3